240 related articles for article (PubMed ID: 8874745)
1. Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.
Fritsch C; Verwohlt B; Bolsen K; Ruzicka T; Goerz G
Arch Dermatol Res; 1996 Aug; 288(9):517-21. PubMed ID: 8874745
[TBL] [Abstract][Full Text] [Related]
2. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Abels C; Fritsch C; Bolsen K; Szeimies RM; Ruzicka T; Goerz G; Goetz AE
J Photochem Photobiol B; 1997 Aug; 40(1):76-83. PubMed ID: 9301046
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
5. The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolaevulinic acid. Implications in cutaneous photodynamic sensitization.
Casas A; Fukuda H; Di Venosa G; Batlle AM
Br J Dermatol; 2000 Sep; 143(3):564-72. PubMed ID: 10971330
[TBL] [Abstract][Full Text] [Related]
6. Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid.
Fritsch C; Lehmann P; Stahl W; Schulte KW; Blohm E; Lang K; Sies H; Ruzicka T
Br J Cancer; 1999 Mar; 79(9-10):1603-8. PubMed ID: 10188913
[TBL] [Abstract][Full Text] [Related]
7. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
[TBL] [Abstract][Full Text] [Related]
8. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester.
Fritsch C; Homey B; Stahl W; Lehmann P; Ruzicka T; Sies H
Photochem Photobiol; 1998 Aug; 68(2):218-21. PubMed ID: 9723214
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
Fijan S; Hönigsmann H; Ortel B
Br J Dermatol; 1995 Aug; 133(2):282-8. PubMed ID: 7547399
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy in dermatology.
Fritsch C; Goerz G; Ruzicka T
Arch Dermatol; 1998 Feb; 134(2):207-14. PubMed ID: 9487213
[TBL] [Abstract][Full Text] [Related]
13. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
14. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?
Wolf P; Rieger E; Kerl H
J Am Acad Dermatol; 1993 Jan; 28(1):17-21. PubMed ID: 8318069
[TBL] [Abstract][Full Text] [Related]
15. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
Peng Q; Warloe T; Moan J; Heyerdahl H; Steen HB; Nesland JM; Giercksky KE
Photochem Photobiol; 1995 Nov; 62(5):906-13. PubMed ID: 8570730
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
17. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
18. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Peng Q; Soler AM; Warloe T; Nesland JM; Giercksky KE
J Photochem Photobiol B; 2001 Sep; 62(3):140-5. PubMed ID: 11566277
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with 5-aminolevulinic acid induces distinct microcirculatory effects following systemic or topical application.
Schacht V; Szeimies RM; Abels C
Photochem Photobiol Sci; 2006 May; 5(5):452-8. PubMed ID: 16685321
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy.
Fritsch C; Batz J; Bolsen K; Schulte KW; Zumdick M; Ruzicka T; Goerz G
Photochem Photobiol; 1997 Jul; 66(1):114-8. PubMed ID: 9230710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
